DOD Biotech Public Company Limited reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was THB 160.82 million compared to THB 355.53 million a year ago. Revenue was THB 161.38 million compared to THB 355.9 million a year ago. Net loss was THB 0.708914 million compared to net income of THB 55.13 million a year ago. Basic earnings per share from continuing operations was THB 0.012 compared to THB 0.378 a year ago. Diluted earnings per share from continuing operations was THB 0.012 compared to THB 0.378 a year ago. Basic loss per share was THB 0.002 compared to basic earnings per share of THB 0.134 a year ago. Diluted loss per share was THB 0.002 compared to diluted earnings per share of THB 0.134 a year ago.